• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无害整合肿瘤学中补充与替代医学的生物疗法:一例宫颈癌病例

Biological Therapy with Complementary and Alternative Medicine in Innocuous Integrative Oncology: A Case of Cervical Cancer.

作者信息

Chizenga Elvin Peter, Abrahamse Heidi

机构信息

Laser Research Centre, University of Johannesburg, Johannesburg 2028, South Africa.

出版信息

Pharmaceutics. 2021 Apr 28;13(5):626. doi: 10.3390/pharmaceutics13050626.

DOI:10.3390/pharmaceutics13050626
PMID:33924844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8145806/
Abstract

Good medicine is based on good science, inquiry driven and open to new paradigms. For a complex disease such as cancer, a complex treatment regime that is well structured and multifactorial is indispensable. In the present day, Complementary and Alternative Medicine (CAM) therapies are being used frequently for cancer, alongside modern biological therapies and allopathic medicine, in what is called integrative oncology. In all conscience, the use of natural, less invasive interventions whenever possible is ideal. However, a comprehensive understanding of not only the etiopathology of individual cancers, but also the detailed genetic and epigenetic characteristics, the cancer hallmarks, that clearly show the blueprint of the cancer phenotype is a requisite. Different tumors have a common behavioral pattern, but their specific features at the genetic and epigenetic levels vary to a great extent. Henceforth, with so many failed attempts to therapy, drug formulations and combinations need a focused pre-assessment of the inherent features of individual cancers to destroy the tumors holistically by targeting these features. This review therefore presents innocuous therapeutic regimes by means of CAM and integrative medicine approaches that can specifically target the hallmarks of cancer, using the case of cervical cancer.

摘要

好的医学基于良好的科学,以探究为驱动并接纳新的范式。对于像癌症这样的复杂疾病,一个结构合理且多因素的复杂治疗方案是必不可少的。如今,在所谓的整合肿瘤学中,补充和替代医学(CAM)疗法经常与现代生物疗法和对抗疗法一起用于癌症治疗。凭良心说,尽可能使用天然、侵入性较小的干预措施是理想的。然而,不仅要全面了解个体癌症的病因病理学,还要详细了解清楚显示癌症表型蓝图的基因和表观遗传特征,即癌症标志。不同的肿瘤有共同的行为模式,但它们在基因和表观遗传水平上的特定特征差异很大。从今往后,由于治疗、药物配方和联合用药有如此多失败的尝试,需要对个体癌症的固有特征进行有针对性的预先评估,以便通过针对这些特征全面摧毁肿瘤。因此,本综述通过CAM和整合医学方法介绍了无害的治疗方案,这些方案可以以宫颈癌为例,专门针对癌症标志。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/f6ee4e01a9b8/pharmaceutics-13-00626-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/a673a1713a70/pharmaceutics-13-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/ea41748c4963/pharmaceutics-13-00626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/dffcde94d98f/pharmaceutics-13-00626-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/f6ee4e01a9b8/pharmaceutics-13-00626-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/a673a1713a70/pharmaceutics-13-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/ea41748c4963/pharmaceutics-13-00626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/dffcde94d98f/pharmaceutics-13-00626-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef7/8145806/f6ee4e01a9b8/pharmaceutics-13-00626-g004.jpg

相似文献

1
Biological Therapy with Complementary and Alternative Medicine in Innocuous Integrative Oncology: A Case of Cervical Cancer.无害整合肿瘤学中补充与替代医学的生物疗法:一例宫颈癌病例
Pharmaceutics. 2021 Apr 28;13(5):626. doi: 10.3390/pharmaceutics13050626.
2
Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients.评估乳腺癌和妇科癌症患者对综合医学疗法的需求。
Breast Care (Basel). 2019 Mar;14(1):35-40. doi: 10.1159/000492235. Epub 2018 Oct 23.
3
The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.参与身心与能量疗法的艾滋病病毒感染者的经历:定性证据的系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):41-9. doi: 10.11124/jbisrir-2015-2321.
4
Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients' needs.孕期和产褥期妇女对整合医学的需求:一项针对患者需求的德国调查。
BMC Complement Altern Med. 2018 Jun 15;18(1):187. doi: 10.1186/s12906-018-2249-y.
5
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.德国乳腺癌患者补充和整合医学的使用:PRAEGNANT研究网络中的预测因素及对患者护理的影响
Arch Gynecol Obstet. 2017 May;295(5):1239-1245. doi: 10.1007/s00404-017-4348-2. Epub 2017 Mar 22.
6
Putting Integrative Oncology Into Practice: Concepts and Approaches.将整体肿瘤医学付诸实践:概念与方法。
J Oncol Pract. 2019 Jan;15(1):7-14. doi: 10.1200/JOP.18.00554.
7
Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy.评价专家指导的综合治疗方案在接受系统治疗的乳腺癌或妇科癌症患者中的应用。
J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20949444. doi: 10.1177/2515690X20949444.
8
Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.使用顺势疗法咨询综合肿瘤学诊所的乳腺癌患者的临床特征和治疗行为:登记数据分析。
BMC Complement Med Ther. 2023 Nov 3;23(1):395. doi: 10.1186/s12906-023-04219-x.
9
Nutraceuticals and Behavioral Therapy for Headache.头痛的营养疗法和行为疗法。
Curr Neurol Neurosci Rep. 2021 May 10;21(7):33. doi: 10.1007/s11910-021-01120-3.
10
Review of complementary and alternative medicine and selected nutraceuticals: background for a pilot study on nutrigenomic intervention in patients with advanced cancer.补充与替代医学及特定营养保健品综述:晚期癌症患者营养基因组干预试点研究的背景
Altern Ther Health Med. 2012 Mar-Apr;18(2):26-34.

引用本文的文献

1
The Role of Medical Therapies in the Management of Cervical Intraepithelial Neoplasia: A Narrative Review.医学治疗在宫颈上皮内瘤变管理中的作用:一项叙述性综述
Medicina (Kaunas). 2025 Feb 13;61(2):326. doi: 10.3390/medicina61020326.
2
Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions.用于治疗人乳头瘤病毒诱导病变的咪喹莫特纳米系统。
Pharmaceutics. 2024 Jun 27;16(7):864. doi: 10.3390/pharmaceutics16070864.
3
Essential Oils in Cervical Cancer: Narrative Review on Current Insights and Future Prospects.

本文引用的文献

1
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy.用于癌症免疫治疗的调节性T细胞中的CTLA-4
Cancers (Basel). 2021 Mar 22;13(6):1440. doi: 10.3390/cancers13061440.
2
Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia.营养保健品与运动防治癌症恶病质相关肌肉消耗
Cells. 2020 Nov 24;9(12):2536. doi: 10.3390/cells9122536.
3
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.新辅助帕唑帕尼治疗和肾细胞癌组织反应的分子分析。
宫颈癌中的精油:当前见解与未来前景的叙述性综述
Antioxidants (Basel). 2023 Dec 13;12(12):2109. doi: 10.3390/antiox12122109.
4
Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy.同步放化疗治疗宫颈癌后患者的生活质量。
Medicina (Kaunas). 2023 Apr 17;59(4):777. doi: 10.3390/medicina59040777.
5
Cancer Mechanisms and Emerging Therapies.癌症机制与新兴疗法
Pharmaceutics. 2021 Jul 9;13(7):1045. doi: 10.3390/pharmaceutics13071045.
JCI Insight. 2020 Nov 19;5(22):132852. doi: 10.1172/jci.insight.132852.
4
Mindfulness-Based Programs for Patients With Cancer via eHealth and Mobile Health: Systematic Review and Synthesis of Quantitative Research.基于正念的电子健康和移动健康癌症患者项目:定量研究的系统评价和综合。
J Med Internet Res. 2020 Nov 16;22(11):e20709. doi: 10.2196/20709.
5
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan.贝伐珠单抗相关事件在日本宫颈癌女性中的研究:日本近畿妇产科学会的多机构调查。
Int J Clin Oncol. 2021 Mar;26(3):598-605. doi: 10.1007/s10147-020-01826-3. Epub 2020 Nov 13.
6
Pembrolizumab for advanced cervical cancer: safety and efficacy.帕博利珠单抗治疗晚期宫颈癌:安全性和疗效。
Expert Rev Anticancer Ther. 2021 Feb;21(2):221-228. doi: 10.1080/14737140.2021.1850279. Epub 2020 Nov 26.
7
Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.放化疗联合抑制 Tregs 增强直肠癌的远隔抗肿瘤效应并抑制转移。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-000826.
8
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC.双重 EGFR-VEGF 通路抑制:EGFR 突变型 NSCLC 患者的有前途策略。
J Thorac Oncol. 2021 Feb;16(2):205-215. doi: 10.1016/j.jtho.2020.10.006. Epub 2020 Oct 20.
9
Clinical landscape of oncolytic virus research in 2020.2020 年溶瘤病毒研究的临床格局。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001486.
10
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer.阿替利珠单抗联合贝伐珠单抗治疗晚期宫颈癌的 II 期研究。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001126.